Lv1
68 积分 2023-11-21 加入
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
1个月前
已完结
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
1个月前
已完结
Health-related quality of life (HRQL) assessments in a 52-week, double-blind, randomized, placebo-controlled phase III study of resmetirom (MGL-3196) in patients with metabolic dysfunction–associated steatohepatitis (MASH) and fibrosis
2个月前
已完结
Dietary anthocyanins alleviates age-dependent hepatic steatosis by expanding Limosilactobacillus reuteri and modulating gut microbiota–bile acid–hepatic FXR signaling
6个月前
已完结
Host metabolism balances microbial regulation of bile acid signalling
10个月前
已完结
Prediction of Weight Loss and Regain Based on Multiomic and Phenotypic Features: Results From a Calorie-Restricted Feeding Trial
10个月前
已完结
Associations between Sensitivity to Thyroid Hormones and Visceral Adiposity in Euthyroid Adults
11个月前
已完结
Hepatic insulin resistance affects the efficacy of metformin in patients with newly diagnosed type 2 diabetes: A Sub-Analysis of the MARCH trial
1年前
已完结
Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis
1年前
已完结
Influence of Roux-en-Y gastric bypass on plasma bile acid profiles: a comparative study between rats, pigs and humans
1年前
已完结
皖公网安备34019202002308
